Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Results
Phase 3
This trial compared bosutinib with imatinib to treat newly diagnosed chronic myeloid leukaemia (CML).
Recruitment start: 15 July 2014
Recruitment end: 20 August 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jenny Byrne
NIHR Clinical Research Network: Cancer
Avillion
Pfizer
Last reviewed: 06 Sept 2018
CRUK internal database number: 12507
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
